Figure (Um Logo)
Humalog
Product Images NDC 54868-4381
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Humalog (NDC 54868-4381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 3 (Hlg Mix75 F004 V02)
Two line graphs comparing glucose infusion rates over 12 hours after dosing. The first graph shows data for Humalog Mix75/25 with a rapid rise peaking near 2 hours and gradual decline. The second graph shows Humulin 70/30 with a slower rise peaking near 3 hours and more gradual taper. Both graphs plot glucose infusion rate (mg/min/kg) versus time after dosing (hours).*
Primary Structure (Humalog F003 V1)
Chemical structure diagram of the insulin molecule showing the A-chain and B-chain amino acid sequences connected by disulfide bonds. The illustration highlights the positions of individual amino acids in each chain.*
Figure 1 (Humalog Mix7525 F002 V01)
A line graph comparing serum insulin receptor concentrations (mU/L) over time (hours) after dosing for two insulin formulations: Humalog Mix 75/25 and Humulin 70/30. The x-axis represents time after dosing (0 to 12 hours), and the y-axis shows serum IR concentrations from 0 to 50 mU/L. Humalog Mix 75/25 is represented by a solid line, peaking earlier and higher than Humulin 70/30, which is shown with a dotted line.*
Figure 2 (Humalog Mix7525 F003 V01)
A line graph showing glucose infusion rate (mg/min/kg) versus time (hours after dosing) comparing Humalog, Humalog Mix 50/50, Humalog Mix 75/25, and an NPL component. The graph illustrates glucose infusion rates over 24 hours post dosing for these formulations.*
Figure (Humalogmix75 Um 10 V1)
Illustration showing a hand pulling a blue protective cap or cover off an insulin pen device. The image depicts the initial step to prepare the pen for injection or dose setting.*
Figure (Humalogmix75 Um 11 V1)
An illustration showing a hand holding a syringe or pen-like device containing medication, with the thumb pushing or adjusting the dosage. The image appears to demonstrate how to handle or administer an injection using the device.*
Figure (Humalogmix75 Um 12 V1)
An instructional illustration showing a person holding a syringe for Humalog Mix75/25, with a close-up of the needle inserted into the vial. A clock indicates to hold the syringe in position for 5 seconds, illustrating part of the medication preparation process.*
Figure (Humalogmix75 Um 13 V1)
An instructional diagram showing a hand turning the dose knob on an insulin pen device. The illustration includes an upward-pointing arrow indicating the direction to turn the dose knob for dose selection or adjustment.*
Figure (Humalogmix75 Um 14 V1)
An instructional illustration showing a hand holding an insulin pen, positioned to inject insulin into the thigh area of a person's leg. The image indicates the injection site and demonstrates proper injection technique for administering Humalog Mix75/25 insulin.*
Figure (Humalogmix75 Um 15 V1)
An instructional illustration showing a hand shaking a vial for 5 seconds. The vial label features the Eli Lilly logo. This demonstrates the preparation step for administering the medication.*
Figure (Humalogmix75 Um 16 V1)
An instructional illustration depicting the removal of a cap from a syringe or pen device by a hand pulling the cap off in the indicated direction with a red arrow. The image suggests preparation of the device for use.*
Figure (Humalogmix75 Um 17 V1)
An instructional illustration showing a hand holding a pen-like injector device near a vial, with a red arrow indicating the direction to attach or insert the vial into the device, presumably related to the use of Humalog Mix75/25 insulin.*
Figure (Humalogmix75 Um 18 V1)
Humalog Mix75/25 cartridge packaging label showing the product in a blue and white box. The label displays a close-up image of the insulin cartridge with readable markings, branded with Humalog Mix75/25. The box features Physicians Total Care, Inc. as the labeler.*
Figure (Humalogmix75 Um 19 V1)
An instructional illustration showing a person preparing a Humalog Mix75/25 insulin pen by removing the protective cap from the pen needle. The image depicts hands holding the insulin pen and needle with an arrow indicating the direction to pull off the cap.*
Figure (Humalogmix75 Um 2 V1)
An instructional diagram illustrating the parts of a pen needle, labeled as Outer Needle Shield, Inner Needle Shield, Needle, and Paper Tab. The diagram clarifies that needles are not included and visually separates each component of the pen needle assembly.*
Figure (Humalogmix75 Um 20 V1)
Chemical structure diagram depicting the active ingredients of Humalog Mix75/25, an insulin product by Physicians Total Care, Inc. The image shows detailed molecular configurations representative of insulin analogs.*
Figure (Humalogmix75 Um 3 V1)
An instructional illustration labeled 'KwikPen Parts' showing the components of an insulin pen device. Parts identified include the Pen Cap, Rubber Seal, Cartridge Holder with insulin dosage markings, Pen Body with label space, and the Dose Indicator featuring the Dose Window and Dose Knob.*
Figure (Humalogmix75 Um 4 V1)
An instructional illustration showing two hands holding components that appear to be parts of a pen injector device. One hand holds a blue pen cap with an arrow indicating it should be pulled off from the pen body held by the other hand, suggesting the first step in preparing the device for use.*
Figure (Humalogmix75 Um 5 V1)
An illustration showing two hands; one hand holds an object while the other hand moves the object side to side, indicated by a double-headed horizontal arrow. This likely depicts shaking or mixing the product before use.*
Figure (Humalogmix75 Um 6 V1)
An instructional illustration showing a hand holding a syringe and preparing to inject subcutaneously into a person's skin on the thigh. The image demonstrates the injection technique, including pinching the skin and inserting the needle at an angle.*
Figure (Humalogmix75 Um 7 V1)
An instructional illustration showing a person's hand holding a syringe with a capped needle, preparing or removing the needle cap. The image focuses on the syringe and needle, demonstrating safe handling of the injection device.*
Figure (Humalogmix75 Um 8 V1)
An instructional diagram showing a hand holding a Humalog Mix75/25 pen injector and demonstrating the proper technique for moving or positioning the pen by pivoting it up and down using indicated red arrows. The image guides users on how to prepare the pen for injection.*
Figure (Humalogmix75 Um 9 V1)
An instructional illustration showing a hand attaching a needle to a syringe or insulin pen device. A red arrow indicates the direction to push the needle onto the device. The image is likely part of usage instructions for Humalog Mix75/25.*
Figure (Humalogmix75 Um1 V1)
Humalog Mix75/25 prefilled insulin pen by Physicians Total Care, Inc. The device is primarily blue with a white middle section and a blue cap on the right. The pen features an Eli Lilly logo on the end cap.*
Package Carton – Humalog Mix75/25 10 mL Vial 1ct (Package Label)
Label for Humalog Mix 75/25 insulin distributed by Physicians Total Care, Inc., Tulsa, OK. Includes the NDC 54868-4381 and shows manufacturer as Eli Lilly and Company, Indianapolis, IN. Also displays lot and expiration date information along with a barcode.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
